# Comparison of Sufentanil, Fentanyl and Remifentanil in Combination With Midazolam During Bronchoscopy Under Conscious Sedation

> **NCT03901716** · PHASE4 · COMPLETED · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 60 (actual)

## Conditions studied

- Sufentanil
- Remifentanil
- Fentanyl
- Bronchoscopy
- Narcotrend
- Conscious Sedation

## Interventions

- **DRUG:** Sufentanil
- **DRUG:** Fentanyl
- **DRUG:** Remifentanil
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT03901716
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2019-03-15
- **Final completion:** 2019-03-26
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03901716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03901716, "Comparison of Sufentanil, Fentanyl and Remifentanil in Combination With Midazolam During Bronchoscopy Under Conscious Sedation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03901716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*